411 results on '"Decorti G"'
Search Results
2. SERS of cells: What can we learn from cell lysates?
3. Pharmacogenetics and induction/consolidation therapy toxicities in acute lymphoblastic leukemia patients treated with AIEOP-BFM ALL 2000 protocol
4. PACSIN2 rs2413739 influence on thiopurine pharmacokinetics: validation studies in pediatric patients
5. P084 Investigation of non-coding RNAs as molecular markers during glucocorticoid treatment in children with inflammatory bowel disease
6. MIF plasma level as a possible tool to predict steroid responsiveness in children with idiopathic nephrotic syndrome
7. Understanding thiopurine methyltransferase polymorphisms for the targeted treatment of hematologic malignancies
8. Cancer Pharmacogenetics: perspective on newly discovered and implemented predictive biomarkers
9. PACSIN2 rs2413739 influence on thiopurine pharmacokinetics: validation studies in pediatric patients
10. Letter: TPMT activity and age in IBD patients
11. P364 New insights into the molecular mechanisms of thalidomide in paediatric inflammatory bowel disease patients
12. P076 Role of gut microbiota in mediating the effects of thiopurines
13. MICRORNAS ARE INVOLVED IN GLUCOCORTICOID RESISTANCE REVERSION BY RAPAMYCIN THROUGH SUPPRESSION OF THE JNK SIGNALING PATHWAY
14. TPMT genotype and the use of thiopurines in paediatric inflammatory bowel disease
15. Adriamycin-induced histamine release from heart tissue in vitro
16. Role of MDR1 gene polymorphisms in gingival overgrowth induced by cyclosporine in transplant patients
17. Thiopurine-S-methyltransferase genotype and the response to azathioprine in inflammatory bowel disease
18. Glucocorticoid receptor polymorphisms in inflammatory bowel disease
19. Glucocorticoid resistance in a girl with Takayasu’s arteritis
20. Effect of the carboxylic ionophore monensin on histamine release from rat peritoneal mast cells
21. Thalidomide-induced peripheral neuropathy in children with inflammatory bowel disease
22. Pharmacogenetics and induction/consolidation therapy toxicities in acute lymphoblastic leukemia patients treated with AIEOP-BFM ALL 2000 protocol
23. Role of inosine triphosphate pyrophosphatase gene variant on fever incidence during zidovudine antiretroviral therapy
24. Ruolo dei polimorfismi genetici sulla tossicità nella terapia della leucemia linfoblastica acuta in pazienti pediatrici
25. Ruolo dei polimorfismi genetici sulla tossicità nella terapia della leucemia linfoblastica acuta in pazienti pediatrici
26. Pharmacogenetics of glucocorticoid response
27. The action of polyphenols on the cardio-vascular system and the ability of bilitranslocase
28. Pharmacogenetics and induction/consolidation therapy toxicities in acute lymphoblastic leukemia patients treated with AIEOP-BFM ALL 2000 protocol
29. Physiological regulation of P-glycoprotein, MRP1, MRP2 and cytochrome P450 £A2 during rat ontology
30. Physiological regulation pf P-glycoprotein, MRP1, MRP2 and cytochrome P450 3A2 during rat ontogeny
31. Dimethyl sulfoxide inhibits histamine release induced by various chemicals
32. Effect of periodontal therapy on the course of cyclosporin-induced gingival overgrowth: role of ABCB1 and PAI-1 gene polymorphisms
33. Toxicology and pharmacokinetic study of low doses of verapamil combined with doxorubicin
34. Multicentric study on azathioprine dose and pharmacokinetics in early-onset pediatric inflammatory bowel disease
35. Pharmacogenetic determinants of response to infliximab in pediatric inflammatory bowel disease
36. Long Noncoding RNA GAS5: A Novel Marker Involved in Glucocorticoid Response
37. Interaction of adriamycin with rat and mouse mast cells: Histamine release and cellular uptake
38. Evidence for the lack of involvement of free radicals in adriamycin-induced histamine release from rat peritoneal cells
39. Grape anthocyanins are absorbed from stomach and incorporated in liver, kidneys and brain
40. P-098: Azathioprine dose and pharmacokinetics in early-onset pediatric inflammatory bowel disease
41. Hepatic uptake of dietary anthocyanins and the role of bilitranslocase
42. PReS-FINAL-2338: Fate of lymphocytes after withdrawal of Tofacitinib treatment
43. PReS-FINAL-2165: Pharmacogenetic determinants of response to methotrexate in juvenile idiopathic arthritis
44. PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity
45. Glutathione S-Transferase homozygous deletions on relapse in childhood Acute Lymphoblastic Leukemia: a novel study design in a large Italian AIEOP cohort.
46. Expression of P-170 glycoprotein in normal cells: its role in anthracycline toxicity and effect of reverting agents
47. Transport of doxorubicin in the LLC-PK1 porcine kidney cell line
48. Pharmacogenomic Approaches for Tailored Anti-Leukemic Therapy in Children
49. In vitro sensitivity to methyl-prednisolone is associated with clinical response in pediatric idiopathic nephrotic syndrome.
50. Ultrastructural and biochemical studies on mast cell exocytosis induced by adriamycin at different temperatures
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.